200 1 Department of Cardiovascular Diseases of Heilongjiang College of Traditional Chinese Medicine was designated as "National Key College of Cardiovascular Diseases of Traditional Chinese Medicine" by state administration of traditional chinese medicine, with 2 famous Chinese medicine practitioners, 6 chief physicians and 60 open beds in Heilongjiang Province. It has advanced equipment such as Philips central monitor, 24-hour dynamic ECG monitoring, telemetry ECG monitoring system, defibrillation monitor, etc., equipped with CCU ward, and established cooperative networks with more than 20 Chinese medicine hospitals across the country.
The key specialty adheres to the overall concept of TCM and the principle of syndrome differentiation and treatment, focusing on TCM treatment and combining traditional Chinese and western medicine. The total effective rate of treating coronary heart disease is over 95%, and the total effective rate of treating hypertension is 95.2%. He creatively developed the theory of treating heart with traditional Chinese medicine, and was the forerunner of treating heart disease with TCM classification.
To lay a foundation for pharmacological research of coronary heart disease.
1962 The Research Institute of Traditional Chinese Medicine (Zuyan), the predecessor of Heilongjiang Research Institute of Traditional Chinese Medicine, established an arteriosclerosis research group, which was divided into clinical group and experimental group.
Modern pharmacological research needs to start with animal experiments, and how to make experimental animals "patients" with arteriosclerosis is the first problem to be solved. Through unremitting exploration, the experimental group successfully established the modeling method of arteriosclerosis, which made it possible for experimental animals to verify the efficacy of drugs and laid the foundation for the study of arteriosclerosis.
Pioneer of the concept of "typing therapy"
Traditional Chinese medicine (TCM) is a wonderful work of world medicine that has been verified for thousands of years. However, due to the imperfect standards, it is difficult to solve the problem of "when it works". From 1965, Zuyan Atherosclerosis Research Group began to study the curative effect of syndrome differentiation on coronary atherosclerosis and angina pectoris. According to the clinical manifestations of patients, it can be divided into two types: attack stage and remission stage. The attack stage can treat the symptoms and the remission stage can cure the root cause. The attack period can be divided into two types: phlegm and blood stasis. The remission stage is divided into liver and spleen deficiency type, liver and kidney yin deficiency type and yin and yang deficiency type. This method of classified treatment was advanced in the field of traditional Chinese medicine at that time.
From 1972 to 1977, Zu Yan focused on the clinical classification of angina pectoris. Through the systematic observation of 88 inpatients, the study of syndrome differentiation and treatment was carried out, and satisfactory results were obtained: the effective rate was 77.5%; Qi stagnation and blood stasis type, the effective rate reached 73.8%; Deficiency of both qi and yin, the effective rate is 80%; The effective rate was 83.2%. 88 patients were treated for 3 months ~ 1 year, and no myocardial infarction occurred.
According to the experience of Zuyan experts, "type" is not static, but only reflects the clinical manifestations at a certain stage in the process of disease evolution, and cannot represent the whole process of disease. With the therapeutic effect and the evolution of "evil" and "positive" diseases, the types will also change.
Developing theory of treating mind
It is generally believed that qi-invigorating drugs will increase patients' blood pressure and accelerate their heartbeat, so they should not be used in patients with coronary heart disease and angina pectoris. However, Zuyan's experts found in clinical practice that patients often suffer from fatigue and limb weakness due to excessive blood circulation during treatment. However, in the process of applying drugs such as ginseng and astragalus, the blood pressure of patients with hypertension decreased and patients with tachycardia turned normal. Based on this, Zuyan experts believe that the key to blood stasis is qi deficiency, because qi and blood are parallel, and qi deficiency means blood stasis, and put forward that "promoting blood circulation without forgetting qi", supplementing qi and promoting blood circulation is the key problem in treating coronary heart disease and angina pectoris. The article "Clinical Observation on Treating Angina Pectoris of Coronary Heart Disease 104 Cases Mainly by Supplementing Qi" was completed clinically, which attracted wide attention in the field of traditional Chinese medicine.
On the basis of in-depth research, Zuyan experts put forward the view that coronary heart disease "is rooted in the kidney from the exterior to the heart". Treating coronary heart disease and arrhythmia with the unique method of tonifying kidney, invigorating qi and promoting blood circulation can control the progressive aggravation of myocardial ischemia and arrhythmia, improve electrocardiogram, prevent or delay the occurrence of myocardial infarction, heart failure and cardiogenic shock, and enrich and develop the theory of treating coronary heart disease in traditional Chinese medicine.
National leading scientific research level
1June, 1984, the Ministry of Health set up the national chest obstruction and heartache cooperation group, which was designated as a member unit of 16 nationwide, and the Zuyan Coronary Heart Disease Research Office was one of the participating units. The laboratory cooperates with a group of experts from all over the country to tackle key problems and study a fast, efficient and stable treatment method for chest obstruction and heartache. After more than two years of clinical observation and research, Xintong aerosol was made. After expert appraisal, it is considered that Xintong Aerosol is rigorous in design, scientific, safe and reliable in curative effect, and won the second prize of state administration of traditional chinese medicine Science and Technology Progress Award 1986.
1992 led by Guo, director of the department, participated in the "Clinical and Experimental Study on Treating Angina Pectoris with Buxin Yiqi and Zixinyin Oral Liquid", and won the 1993 second-class achievement award in state administration of traditional chinese medicine and the new drug certificate and production approval issued by the Ministry of Health.
Based on the new view that the root of coronary heart disease lies in kidney, Shenwu Guanxin Granule takes tonifying kidney and benefiting qi, promoting blood circulation and relieving pain as the basic methods to treat coronary heart disease. Clinical observation shows that the total effective rate is 965438 0.2%. This research won the third prize of Heilongjiang Science and Technology Progress Award 1996.
In 2004, Professor Xu Huimei presided over the "Research on the Development of New Drugs for Treating Premature Beats with Anlv Capsule" and won the third prize of scientific and technological progress in Heilongjiang Province. Guo's "Effect of Xinsaitong Oral Liquid on the Area of Acute Myocardial Infarction" won the third prize of scientific and technological progress in Heilongjiang Province. In 2005, the "Experimental Study of Fumaikang Capsule in Treating Bradycardia" presided by Xu Huimei passed the appraisal of scientific research results. (Article source: China journal of traditional chinese medicine No.2675)
Tel: 045 1-55653080 (General)
Hospital address: No.3 Fu Street 142, Xiangfang District, Harbin
Postal code of hospital: 150036
Department of Cardiology, First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
The Department of Cardiology of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine was established in 2000. The existing bed in the indoor department of undergraduate course is Dr. Zhang. Among them, there are chief physician, China cooperative physician, the earliest master, master, doctor, postgraduate diagnosis tutor, master's degree expert, postgraduate tutor studying abroad and excellent department. Always strictly adhere to the development direction of integrated traditional Chinese and western medicine, give full play to the characteristics of specialties, and combine disease differentiation and syndrome differentiation to make Chinese medicine clinical in the United States. Professor Li Liu is a standardized leader of diagnosis and treatment discipline, chief professional physician, knowledge-based medical training and doctoral supervisor of doctoral jury in Shenyang. He was awarded Sasakawa Medical Scholarship in, studied cardiovascular medicine in Japan Independent Medical University for one year, and graduated from the jury of integrated traditional Chinese and western medicine, majoring in cooperative diagnosis and treatment of cardiovascular diseases. He has many rich natural experiences in Japan.
The Associate Professor of Traditional Chinese Medicine Treatment in the Department of Cardiology, Heilongjiang, the First Affiliated Hospital of the University, makes use of the advantages of being in line with the provincial level of key specialties, and strives to combine knowledge teaching, scientific research and study abroad departments with clinical practice to cultivate an excellent medical English team. With the help of the platform of TV media, a special lecture was held in the column of "See the doctor every day" and "Expert Delivery Lecture" of Harbin TV Station. The famous doctors successfully established the hypertension specialist outpatient service and the follow-up system for hypertension patients, and the researcher departments successively passed. The main research directions are: coronary heart disease, heart failure, arrhythmia, hypertension, metabolic disease, valvular disease and hyperlipidemia, and the developed "Lixin I" and "Zaoboling" have achieved satisfactory results in the earliest clinical discovery and application.
Heilongjiang University of Traditional Chinese Medicine has the First Affiliated Hospital, and the Second Ward of Cardiovascular Medicine was established in 2000. The existing department system is that the chief physician connects, the master accumulates, and the deputy director manages the nurses. Among them, there is a doctor's degree in rescue, and a master's degree is good at enriching Chinese medicine departments. In addition, the disciplines of internal medicine and cardiovascular diseases are provincial key combined disciplines. Professor Zhou Yabin is the last professor, doctoral supervisor in distinguished professor, and a scholar in Longjiang, Liaoning Province, with a capacity of 100,000 in the new century. Ten thousand scientific research talents, engineering society and national-level candidates, provincial-level key disciplines of internal medicine of traditional Chinese medicine, are now leaders of cardiovascular diseases, deputy director of immunology, professor of hygiene in Chen Bo, comprehensive tutor of China, and master of traditional Chinese medicine at school level; Professor Wang Xiujuan, deputy director of the American Cooperation Department, is the heir of social medicine in China and Laos.
Professor of Heilongjiang University of Medicine, Second Ward of Cardiovascular Long-term Internal Medicine, First Affiliated Hospital, has experience in bedside telemetry ECG monitoring defibrillator and other treatment equipment. Over the years, under the leadership of Professor Zhou Yabin, the academic leader, the medical teaching and scientific research work in the department has achieved fruitful results. In recent years, it has won the second prize and the third prize of provincial and ministerial level scientific and technological progress. He has rich clinical experience in coronary heart disease, angina pectoris, arrhythmia, viral myocarditis, hypertension, heart failure and Alzheimer's disease. The nursing work of the department is carried out with the holistic nursing of "Human Health Center" to provide for the majority of patients.
The third ward of Cardiology Department of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine is located on the first floor of the first ward. There are beds, superior rooms, medical staff, chief physician, deputy chief physician, doctor's name, doctor's doctorate and master's degree. This ward mainly treats patients with cardiovascular and cerebrovascular diseases and some patients with cerebrovascular diseases, including coronary heart disease, cor pulmonale, cardiomyopathy, hypertension, arrhythmia, stroke, etc., which not only highlights the characteristics of traditional Chinese medicine, but also actively uses modern medical means to treat arrhythmia caused by coronary heart disease, heart failure and so on. There are three research topics and pace installation technology in our ward.
The Third Ward of Cardiovascular Department of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine is actively developing new technologies, and many doctors have gone out to study the knowledge of cardiac intervention, laying the foundation for future cardiac intervention therapy.